• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 5. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives m-Xylenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Xylenes m-Xylenes

Introduction to 2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE (CAS No. 79927-86-9)

2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE, identified by the Chemical Abstracts Service Number (CAS No.) 79927-86-9, is a significant compound in the realm of organic chemistry and pharmaceutical research. This aromatic hydrocarbon derivative features a bromoethyl substituent attached to a dimethylbenzene core, making it a versatile intermediate in synthetic chemistry. The unique structural properties of this compound have garnered attention for its potential applications in medicinal chemistry, particularly in the development of novel therapeutic agents.

The molecular structure of 2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE consists of a benzene ring substituted with two methyl groups at the 1 and 3 positions, and an ethyl group linked to a bromine atom at the 2 position. This configuration imparts distinct reactivity, enabling it to participate in various chemical transformations such as nucleophilic substitution, cross-coupling reactions, and functional group interconversions. These characteristics make it a valuable building block for constructing more complex molecules.

In recent years, the pharmaceutical industry has increasingly focused on developing small-molecule inhibitors targeting specific biological pathways. 2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE has emerged as a key intermediate in the synthesis of such inhibitors due to its ability to undergo selective modifications. For instance, its bromoethyl side chain can be readily functionalized to introduce diverse pharmacophores, facilitating the design of molecules with enhanced binding affinity and selectivity towards therapeutic targets.

One of the most compelling applications of 2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE lies in its utility as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways and are frequently implicated in various diseases, including cancer. By modifying the structure of 2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE, researchers can generate novel kinase inhibitors that disrupt aberrant signaling cascades. Recent studies have demonstrated the efficacy of compounds derived from this scaffold in preclinical models, highlighting its promise as a starting point for drug discovery.

The bromine atom in 2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE serves as a reactive handle for further functionalization through palladium-catalyzed cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions allow for the introduction of aryl or heteroaryl groups into the molecule, expanding its chemical diversity. Such modifications are essential for optimizing pharmacokinetic properties and minimizing off-target effects.

Moreover, 2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE has found utility in the development of probes for biochemical assays. Its ability to undergo selective labeling enables researchers to track specific molecular interactions in vitro and in vivo. This capability is particularly valuable in understanding complex biological systems and identifying new therapeutic intervention points.

The synthesis of 2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE typically involves Friedel-Crafts alkylation followed by bromination and subsequent ethylation steps. Advances in synthetic methodologies have improved the efficiency and scalability of these processes, making it more accessible for industrial applications. The optimization of these synthetic routes has been a focus of recent research efforts aimed at reducing costs and improving yields.

In conclusion, 2-(2-BROMOETHYL)-1,3-DIMETHYLBENZENE (CAS No. 79927-86-9) is a multifaceted compound with broad applications in pharmaceutical research and drug development. Its unique structural features and reactivity make it an indispensable tool for chemists seeking to design novel therapeutic agents targeting various diseases. As research continues to uncover new biological targets and synthetic strategies, 2-(2-BROMOETHYL)-1,3-DIMETHBENZENE is poised to remain at the forefront of medicinal chemistry innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)